Leqembi is the first Alzheimer’s antibody treatment to receive full FDA approval.
Source:https://www.cnbc.com/2023/07/07/eisai-shares-tumble-despite-receiving-fda-greenlight.html
Source:https://www.cnbc.com/2023/07/07/eisai-shares-tumble-despite-receiving-fda-greenlight.html
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
Subscribe now to keep reading and get access to the full archive.